Aprogen Medicines Inc. (KRX:007460)
South Korea · Delayed Price · Currency is KRW 293.00
-24.00 (-7.57%)
Apr 15, 2026, 9:54 AM KST
Aprogen Medicines Revenue
In the year 2025, Aprogen Medicines had annual revenue of 117.97B KRW, down -21.41%. Aprogen Medicines had revenue of 31.53B in the quarter ending December 31, 2025, a decrease of -20.48%.
Revenue
117.97B
Revenue Growth
-21.41%
P/S Ratio
0.77
Revenue / Employee
460.84M
Employees
256
Market Cap
90.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 117.97B | -32.14B | -21.41% |
| Dec 31, 2024 | 150.11B | -464.40M | -0.31% |
| Dec 31, 2023 | 150.58B | 72.23B | 92.19% |
| Dec 31, 2022 | 78.35B | 52.05B | 197.95% |
| Dec 31, 2021 | 26.30B | -100.85B | -79.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KG Chemical | 9.10T |
| Samyang Holdings | 3.35T |
| HS HYOSUNG | 1.41T |
| KPX Holdings | 1.16T |
| Woongjin | 1.15T |
| Singsong Holdings | 187.76B |
| Gridwiz | 125.61B |
| HLB GLOBAL | 100.29B |